SymBio Pharmaceuticals (TSE:4582) Total Liabilities : 円718 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Total Liabilities?

SymBio Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2024 was 円718 Mil.

SymBio Pharmaceuticals's quarterly Total Liabilities increased from Sep. 2023 (円773.06 Mil) to Dec. 2023 (円960.33 Mil) but then declined from Dec. 2023 (円960.33 Mil) to Mar. 2024 (円718.35 Mil).

SymBio Pharmaceuticals's annual Total Liabilities increased from Dec. 2021 (円1,707.32 Mil) to Dec. 2022 (円1,927.26 Mil) but then declined from Dec. 2022 (円1,927.26 Mil) to Dec. 2023 (円960.33 Mil).

SymBio Pharmaceuticals Total Liabilities Historical Data

The historical data trend for SymBio Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SymBio Pharmaceuticals Total Liabilities Chart

SymBio Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

873.84

1,617.39

1,707.32

1,927.26

960.33

SymBio Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															823.18	828.51	773.06	960.33	718.35

SymBio Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

SymBio Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	956.625	+	(0	+	-0.0010000000000301
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3.709)
	=	960

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	8170.243	-	7209.91
	=	960

SymBio Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	714.59	+	(0	+	0.00200000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3.762)
	=	718

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	7716.432	-	6998.078
	=	718

SymBio Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of SymBio Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

SymBio Pharmaceuticals (TSE:4582) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SYMQY:USA

Address

5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004

Website

http://www.symbiopharma.com

SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

SymBio Pharmaceuticals (TSE:4582) Headlines

No Headlines